Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0001789970-26-000016

General Counsel sold 16,509 shares at $11.67 ($192,660)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hanson Kristopher · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-16 Sale : show line 1 in the form 10b5-1 −16,509 $11.67 $192,660 137,044 D
Open-market sales · 16,509 sh · avg $11.67 · $192,660
Loading xslF345X06/form4-09182026_040901.xml…